Cargando…
Pulmonary Artery Perfusion with Anti-Tumor Necrosis Factor Alpha Antibody Reduces Cardiopulmonary Bypass-Induced Inflammatory Lung Injury in a Rabbit Model
Inflammatory lung injury is one of the main complications associated with cardiopulmonary bypass (CPB). Tumor necrosis factor-α (TNF-α) is one of the key factors mediating the CPB-induced inflammatory reactions. Our previous studies have shown that endotracheal administration of anti-tumor necrosis...
Autores principales: | Yu, Yang, Gao, Mingxin, Li, Haitao, Zhang, Fan, Gu, Chengxiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873915/ https://www.ncbi.nlm.nih.gov/pubmed/24386164 http://dx.doi.org/10.1371/journal.pone.0083236 |
Ejemplares similares
-
Pulmonary perfusion reduces accumulation of neutrophils in the lung during cardiopulmonary bypass
por: Schlensak, C, et al.
Publicado: (2003) -
Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial
por: Buggeskov, Katrine B, et al.
Publicado: (2016) -
Comparison of the mid-term clinical efficacy and short-term complications of Y-type coronary artery bypass grafting and sequential bypass grafting of the great saphenous vein: a retrospective cohort study
por: Dai, Longsheng, et al.
Publicado: (2022) -
Short- and Long-Term Patient Outcomes From Combined Coronary Endarterectomy and Coronary Artery Bypass Grafting: A Meta-Analysis of 63,730 Patients (PRISMA)
por: Wang, Jiayang, et al.
Publicado: (2015) -
Pulmonary complications of cardiopulmonary bypass
por: Huffmyer, Julie L., et al.
Publicado: (2015)